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The article by Fauveau et al. [1] in this issue of the Archives of Cardiovascular Diseases
addresses the unusual but spectacular and frightening situation of a thrombus straddling
a patent foramen ovale. Indeed, the ﬁrst point to note in the article is the fact that,
despite their marked interest in this topic, the authors could only gather four personal
cases of a straddling thrombus from three busy cardiology departments. Moreover, their
thorough bibliographic search found fewer than 100 published cases over a 22-year period.
The rarity of straddling thrombi is in sharp contrast with the very high prevalence (about
20%) of patent foramen ovale in the general population. This discrepancy underlines the
need to take great care in incriminating a patent foramen ovale and deciding on its closure
after an otherwise unexplained stroke.
The principal data from the study, however, relate to pulmonary embolism associated
with intra-atrial thrombosis. It should be remembered that pulmonary embolism remains
a true clinical challenge that still has a very high mortality rate (17% mortality at 3months
in the International Cooperative Pulmonary Embolism Registry [ICOPER] [2]).
The role of transthoracic echocardiography in assessing the prognosis of pulmonary
embolism must be emphasized. Although transthoracic echocardiography alone does
not have adequate sensitivity to facilitate diagnosis of an acute pulmonary embolism,
it is a powerful and noninvasive tool for predicting prognosis. Right ventricular dys-
function detected by echocardiography is indeed an independent predictor of early
death [2]. Furthermore, right heart thrombosis, which is observed more often in
patients with critical haemodynamic status, is also a strong marker of adverse outcome
[3,4].
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A thrombus straddling a patent foramen ovale is usually
ound in the setting of massive pulmonary embolism with
r without concomitant stroke. During the past 15 years,
tudies have focused on the relationship between a patent
oramen ovale and undetermined strokes [5]. The most evi-
ent link was the hypothesis of a paradoxical embolism,
hich led to the proposal that a paradoxical embolism
hrough a patent foramen ovale was a more frequent occur-
ence than previously thought.
Most venous thrombi arising from the vena caval ﬂow
n the right atrium are in fact directed to the atrial sep-
um—more precisely, to the fossa ovalis. The foramen ovale
s closed by a ﬂap-like valve on the left side of the left
trium. In patients with cor pulmonae, the raised right-sided
ressures may induce a reopening of the foramen ovale and
right-to-left atrial shunt or an increase of the shunt in
atients with persistent patent foramen ovale, who repre-
ent 18% of the general population.
In a prospective study, contrast echocardiography was
erformed in 139 consecutive patients with a major pul-
onary embolism. A patent foramen ovale was diagnosed
n 48 patients (35%); these patients had a mortality rate
f 33% compared with 14% in patients without a patent
oramen ovale and a signiﬁcantly higher incidence of
schaemic stroke. Contrast echocardiography right-to-left
hunt through a patent foramen ovale is therefore a strong
ndependent predictor of mortality [6].
Owing to the adverse outcome of a patent foramen ovale
n patients with massive pulmonary embolism, aggressive
herapeutic options such as thrombolytic treatment, surgery
ith closure of the patent foramen or catheter thrombus
ragmentation to restore pulmonary vascular patency and
ormalize right-sided haemodynamics should be considered
s soon as possible [7].
The authors emphasize the role of transoesophageal
chocardiography. Obviously, reliable diagnosis of throm-
us trapped in the atrial septum can sometimes be difﬁcult
ith transthoracic echocardiography, but transoesophageal
chography is not without side-effects in patients with mas-
ive pulmonary embolism. The procedure requires sedation,
hich may be difﬁcult if patients are not haemodynamically
table or have severe respiratory distress. If done without
ufﬁcient sedation, transoesophageal echocardiography can
nduce cough efforts that are Valsalva-like maneuvers, rais-
ng right-sided pressures with risk of paradoxical embolism.
n the other hand, more profound sedation in such patients
ay require intubation and ventilation, which in this set-
ing may lead to further deterioration of the haemodynamic
tatus.
Concerning treatment, no randomized trials have com-
ared the results of heparin therapy, thrombolysis and
mbolectomy in any subset of patients with massive acute
ulmonary embolism [8]. Such randomized trials will prob-
bly never be performed.
In theory, thrombolysis may prevent the worsening of
ight-sided heart failure by resolution of the pulmonary
rtery thrombus and much of the source of thrombus,
ecreasing the likelihood of recurrent large pulmonary
mbolism or stroke. Nevertheless, no study has shown a
igniﬁcant effect of thrombolysis on mortality, recurrent
ulmonary embolism or major haemorrhage versus heparin
lone. Thrombolysis in the ICOPER did not reduce mortalityL. Cabanes
or recurrent pulmonary embolism at 90 days) in patients
ith acute massive pulmonary embolism [8].
Several criteria derived from non-randomized trials have
een suggested as indications for surgical embolectomy [9]:
massive pulmonary embolism;
haemodynamic instability despite heparin;
failure of thrombolytic treatment;
contraindications for thrombolysis.
In the very speciﬁc situation of a thrombus straddling a
atent foramen ovale, the risk of clot fragmentation lead-
ng to potential paradoxical embolism with thrombolysis
robably outweighs the potential beneﬁts of thromboly-
is. Emergency surgical embolectomy with cardiopulmonary
ypass allowing concomitant patent foramen ovale closure
nd, if necessary, pulmonary embolus suction appears to be
better therapeutic strategy [10—12]. Aggressive treatment
hould not therefore be regarded as a last-resort strategy;
he results of embolectomy could be optimized if patients
ere referred for this procedure before the onset of car-
iogenic shock or severe systemic embolus such as massive
troke. It should be remembered that most paradoxical
mboli occur early, at the onset of pulmonary embolism,
robably because of the resultant increase in right atrial
ressure, which reopens the unfused fossa ovalis. On the
ther hand, mortality in massive pulmonary embolism seems
o be related more to the consequences of acute right failure
han to the presence of an intra-auricular thrombus [2].
Prognosis in the article by Fauveau et al. [1] related more
trongly to the severity of the initial presentation than to
he therapeutic choices made once the straddling thrombus
as conﬁrmed. Indeed, there were no major outcome differ-
nces between heparin treatment and a surgical approach,
nd the high incidence of adverse outcomes in patients who
eceived thrombolysis can be explained by the severity of
heir clinical presentation.
Heparinotherapy is thus a valid and reasonable option
n patients with comorbidities and a high surgical risk and
hould not be considered as a compassionate treatment.
owever, in patients with a large thrombus trapped in the
nteratrial septum and without severe comorbidity, prompt
urgical embolectomy should be recommended in associa-
ion with closure of the patent foramen ovale to prevent
urther catastrophic recurrent pulmonary and/or systemic
mboli. At that moment, however, this recommendation is
ased on common sense rather than evidence.
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